Duodote auto injectors, fpae NDC # 11704-0620-01
Ended Purchase Order Awarded
- Contract number
- 75P00226P00003
- Awardee
-
Meridian Medical Technologies, LLC UEI VBM4PLZ9VBC4
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $418,638
Award facts
- Contract value 100% obligated
- $418,637.55 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- St. Louis, MO 63146, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Office of the Assistant Secretary for Administration awarded a $418,637.55 firm-fixed-price purchase order to Meridian Medical Technologies, LLC for DuoDote auto-injectors (FPAE NDC #11704-0620-01) with an ultimate completion date of January 5, 2026. The contract was designated as a Total Small Business set-aside, with performance to be executed in St. Louis, Missouri. Meridian Medical Technologies is a wholly-owned subsidiary of Pfizer Inc. specializing in the development and manufacturing of medical countermeasures, particularly autoinjector devices and nerve agent antidote treatments. The company maintains a robust federal contracting presence, having secured awards from multiple agencies including the Department of Health and Human Services, Department of State, U.S. Marshals Service, and Defense Logistics Agency.
This purchase order likely draws from or supports Meridian's broader federal initiatives, including the company's significant $100 million MANDRAKE 3.0 indefinite delivery/indefinite quantity contract with the Department of State Bureau of Medical Services for delivering autoinjectors and training devices globally through September 2028, and its $1 million Other Transaction indefinite delivery vehicle with the Department of Defense's Joint PEO Chemical and Biological Defense for product enhancements to nerve agent autoinjectors. The DuoDote autoinjector is a critical medical countermeasure used for emergency response to nerve agent exposure, making Meridian a strategic supplier for federal agencies managing chemical and biological defense preparedness.
Quick answers
Who was awarded contract 75P00226P00003?
75P00226P00003 was awarded to Meridian Medical Technologies, LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on January 5, 2026.
How much is contract 75P00226P00003 worth?
The government has obligated $418,638 on 75P00226P00003.
Was contract 75P00226P00003 competed?
The extent of competition for 75P00226P00003 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award